Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1/2 4Phase 3 3Phase 4 2Phase 1 2Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Pancreatic Neoplasms 18Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 3Nasopharyngeal Carcinoma 3Recurrence 2Non-Muscle Invasive Bladder Neoplasms 2Lung Neoplasms 2Carcinoma, Hepatocellular 2Biliary Tract Neoplasms 2Uterine Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Nasopharyngeal Neoplasms 1NSCLC 1Malnutrition 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Locally Advanced Pancreatic Cancer 1Infiltrating Bladder Urothelial Carcinoma 1Immunoblastic Lymphadenopathy 1Hypoxia 1Gallbladder Neoplasms 1Cholangiocarcinoma 1

Interventions

Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Mycophenolic Acid 3Etoposide 3Drug Therapy 3Cyclosporine 3fludarabine phosphate 2Melphalan 2Carmustine 2plerixafor 1monomethyl auristatin E 1Vinorelbine 1VAP-cyclo protocol 1Thiotepa 1O(6)-benzylguanine 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Leukapheresis 1Immunoconjugates 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Cytarabine 1Cyclophosphamide 1Carboplatin 1Busulfan 1Brentuximab Vedotin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, T-Cell, Peripheral × Gemcitabine × Clear all
NCT06211881 2024-01-18

Chi-GVM Regimen for the Treatment of R/R PTCL

The First Affiliated Hospital with Nanjing Medical University

Phase NA Unknown
50 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡